Isaiah Sholes had another triple-double for Essex in a defeat, Lo-Ma edged Ar-We-Va, IKM-Manning got 31 from Ben Ramsey, ...

Janssen-Cilag International NV, a Johnson & Johnson company, received European Medicines Agency's Committee for Medicinal Products ...

Halozyme (HALO) announced that Janssen-Cilag International, a Johnson & Johnson (JNJ) company, received a positive opinion from the ...

The Marshalltown girls’ basketball team suffered its eighth-straight loss to Waterloo East, falling 43-27 in Friday’s Iowa ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

North Carolina achieved a record-breaking year for life sciences investments in 2024. Twenty-five companies announced ...

COVID-19 vaccines were not associated with increased risk for thyroid diseases but were associated with increased risk for exacerbated hypothyroidism.

The microbial ecosystems within our mouths may affect our cognitive function as we age, according to a study. Interventions such as prebiotics, including dietary nitrate, have potential for delaying ...

Meanwhile, Dr. Manuel López-Figueroa and Dr. Carlos Buesa will remain on the Board, subject to a positive vote by the Shareholders’ Meeting.

On Tuesday, the US Food and Drug Administration (FDA) approved Johnson & Johnson's hallucinogenic drug esketamine (brand name ...

Another regulatory filing could happen by Johnson & Johnson (JNJ) subsidiary Janssen, for the advancement of AAV-RPGR for the treatment of patients with X-linked Retinitis Pigmentosa [XLRP].

The US Food and Drug Administration has approved a new nasal spray for depression treatment. Known as Spravato and manufactured by Johnson & Johnson, this ketamine-based drug has been approved as a ...